Renz Justin A
SEC insider (Form 3/4/5 filer). CIK 0001466562. CFO at ZEVRA THERAPEUTICS, INC. (ZVRA) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Mar 18, 2026. Located in BOSTON, MA.
Companies Renz Justin A has filed insider reports for
- ZEVRA THERAPEUTICS, INC. (ZVRA): Officer, CFO
- ARDELYX, INC. (ARDX): Officer, Chief Financial Officer
Renz Justin A
CIK: 0001466562
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 18, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
300K shares- - Aug 21, 2025ARDX
ARDELYX, INC.
SaleDirect7K shares at avg. $5.93$42K - May 20, 2025ARDX
ARDELYX, INC.
SaleDirect7.2K shares at avg. $4.08$29K - Feb 25, 2025ARDX
ARDELYX, INC.
AwardDirect136.7K shares- - Feb 20, 2025ARDX
ARDELYX, INC.
SaleDirect5.2K shares at avg. $5.62$29K - Nov 20, 2024ARDX
ARDELYX, INC.
SaleDirect5.3K shares at avg. $4.79$25K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 18, 2026 |  ZVRA ZEVRA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 300,000 | - | - | Direct |
| Aug 21, 2025 |  ARDX ARDELYX, INC. | Sale | 7,037 | $5.93 | $41,741 | Direct |
| May 20, 2025 | ARDX ARDELYX, INC. | Sale | 7,218 | $4.08 | $29,460 | Direct |
| Feb 25, 2025 | ARDX ARDELYX, INC. | Award | 136,680 | - | - | Direct |
| Feb 20, 2025 | ARDX ARDELYX, INC. | Sale | 5,171 | $5.62 | $29,077 | Direct |
| Nov 20, 2024 | ARDX ARDELYX, INC. | Sale | 5,260 | $4.79 | $25,219 | Direct |
1-6 of 6 transactions